The U.S. Food and Drug Administration has approved Cymbalta for chronic back pain and osteoarthritis pain, according to a FDA news release. Cymbalta, which was first used to treat major depressive ...

CHICAGO (Reuters) - Eli Lilly and Co said on Friday it withdrew an application to market its anti-depressant Cymbalta for the management of chronic pain because U.S. health regulators raised questions ...

Indianapolis - Cymbalta may have been launched as an anti-depressant, but it offers relief for low back pain. According to our news gathering partners at the Indianapolis Star, that announcement came ...

The FDA has approved duloxetine (Cymbalta) to treat chronic musculoskeletal pain, including discomfort from osteoarthritis and chronic low-back pain. Several recent randomized trials have evaluated ...

Despite being prescribed fairly commonly, a new study has found that antidepressants provide little to no benefit when it comes to relieving low back pain and sciatica. More research is needed into ...

Cymbalta is approved for children 7 years and older, but Effexor XR is only for adults. Both Cymbalta and Effexor XR have a risk of serotonin syndrome, especially with certain drug interactions.